Skip to main content

United States vs. Elizabeth Holmes

Now that the criminal fraud trial United States vs. Elizabeth Holmes, CEO of the defunct Theranos is over, lawyers are asking questions regarding the responsibilities laboratory directors under CLIA can be impacted and held responsible for violations when comes to lab equipment failures and erroneous test results. Read the verdict and what it may be like inside a white collar prison.

Click here to read more!


More Resources

Resources

Why Automated Systems Cannot Fully Reconcile LIS Orderables

Automated systems excel at executing rules. They are far less effective at validating whether those rules remain correct as laboratory…

Resources

Why LIS and Charge Master Misalignment Is a Structural Risk for Laboratories

Modern laboratory environments rely on multiple interconnected systems to translate clinical activity into revenue. The laboratory information system (LIS) governs…

Education

Small Charge Master Errors Lead to Revenue Leakage and Claim Denials

Laboratories rarely lose revenue all at once. There is no single system outage, no dramatic billing failure, no clear moment…

Education

What the Laboratory Charge Master Really Does in Modern Revenue Cycle Management

Laboratory revenue problems rarely announce themselves clearly. Margins tighten. Denials creep upward. Reimbursement feels inconsistent, even when testing volume is…